LU92549I2 - An albumin fusion protein having GLP-1 activity comprising two tandem-oriented, albumin-fused GLP-1 polypeptides as specified in (i) and (ii) of the patent claim EP1463751; such as an albumin fusion protein having GLP-1 activity, comprising two tandem-oriented GLP-1 polypeptides (7-36 (A8G)) fused to albumin; such as an albumin fusion protein having GLP-1 activity, comprising two tandem-directed GLP-1 polypeptides (7-36 (A8G)) fused to human serum albumin; such as an albumin fusion protein having GLP-1 activity, comprising the amino acid sequence 30-674 of SEQ ID NO: 1280 of EP1463751 such as ALBIGLUTIDE; - Google Patents

An albumin fusion protein having GLP-1 activity comprising two tandem-oriented, albumin-fused GLP-1 polypeptides as specified in (i) and (ii) of the patent claim EP1463751; such as an albumin fusion protein having GLP-1 activity, comprising two tandem-oriented GLP-1 polypeptides (7-36 (A8G)) fused to albumin; such as an albumin fusion protein having GLP-1 activity, comprising two tandem-directed GLP-1 polypeptides (7-36 (A8G)) fused to human serum albumin; such as an albumin fusion protein having GLP-1 activity, comprising the amino acid sequence 30-674 of SEQ ID NO: 1280 of EP1463751 such as ALBIGLUTIDE;

Info

Publication number
LU92549I2
LU92549I2 LU92549C LU92549C LU92549I2 LU 92549 I2 LU92549 I2 LU 92549I2 LU 92549 C LU92549 C LU 92549C LU 92549 C LU92549 C LU 92549C LU 92549 I2 LU92549 I2 LU 92549I2
Authority
LU
Luxembourg
Prior art keywords
glp
albumin
activity
fusion protein
tandem
Prior art date
Application number
LU92549C
Other languages
French (fr)
Original Assignee
Glaxosmithkline Intellectual Property Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Intellectual Property Ltd filed Critical Glaxosmithkline Intellectual Property Ltd
Publication of LU92549I2 publication Critical patent/LU92549I2/en

Links

LU92549C 2001-12-21 2014-09-17 An albumin fusion protein having GLP-1 activity comprising two tandem-oriented, albumin-fused GLP-1 polypeptides as specified in (i) and (ii) of the patent claim EP1463751; such as an albumin fusion protein having GLP-1 activity, comprising two tandem-oriented GLP-1 polypeptides (7-36 (A8G)) fused to albumin; such as an albumin fusion protein having GLP-1 activity, comprising two tandem-directed GLP-1 polypeptides (7-36 (A8G)) fused to human serum albumin; such as an albumin fusion protein having GLP-1 activity, comprising the amino acid sequence 30-674 of SEQ ID NO: 1280 of EP1463751 such as ALBIGLUTIDE; LU92549I2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US34181101P 2001-12-21 2001-12-21

Publications (1)

Publication Number Publication Date
LU92549I2 true LU92549I2 (en) 2014-11-17

Family

ID=49640227

Family Applications (1)

Application Number Title Priority Date Filing Date
LU92549C LU92549I2 (en) 2001-12-21 2014-09-17 An albumin fusion protein having GLP-1 activity comprising two tandem-oriented, albumin-fused GLP-1 polypeptides as specified in (i) and (ii) of the patent claim EP1463751; such as an albumin fusion protein having GLP-1 activity, comprising two tandem-oriented GLP-1 polypeptides (7-36 (A8G)) fused to albumin; such as an albumin fusion protein having GLP-1 activity, comprising two tandem-directed GLP-1 polypeptides (7-36 (A8G)) fused to human serum albumin; such as an albumin fusion protein having GLP-1 activity, comprising the amino acid sequence 30-674 of SEQ ID NO: 1280 of EP1463751 such as ALBIGLUTIDE;

Country Status (2)

Country Link
LU (1) LU92549I2 (en)
SI (1) SI1463751T1 (en)

Also Published As

Publication number Publication date
SI1463751T1 (en) 2013-11-29

Similar Documents

Publication Publication Date Title
US9926351B2 (en) Extended recombinant polypeptides and compositions comprising same
EP2440241B1 (en) Growth hormone polypeptides and methods of making and using same
CN101384623B (en) Process for the production of preformed conjugates of albumin and a therapeutic agent
AU2010258898B2 (en) Glucose-regulating polypeptides and methods of making and using same
JP2017186374A (en) Glucagon-like peptide-2 composition and method for making and using same
US20110172146A1 (en) Growth hormone polypeptides and methods of making and using same
EP1496926A4 (en) Use of transthyretin peptide/protein fusions to increase the serum half-life of pharmacologically active peptides/proteins
JP2004528014A5 (en)
EP2277889A3 (en) Fusion proteins of albumin and interferon beta
JP2007500218A (en) New spacer moiety of poly (ethylene glycol) modified peptide compounds
CA2166870A1 (en) Enzymatic method for modification of recombinant polypeptides
IL157446A0 (en) Increased recovery of active proteins
US20180161443A1 (en) Growth hormone polypeptides and methods of making and using same
UA91820C2 (en) Therapeutic uses of chemokine variants
WO2004074486A3 (en) Fusion proteins of interferon alpha muteins with improved properties
JP2005503763A5 (en)
RU2006132384A (en) Fused Protein Albumin
LU92549I2 (en) An albumin fusion protein having GLP-1 activity comprising two tandem-oriented, albumin-fused GLP-1 polypeptides as specified in (i) and (ii) of the patent claim EP1463751; such as an albumin fusion protein having GLP-1 activity, comprising two tandem-oriented GLP-1 polypeptides (7-36 (A8G)) fused to albumin; such as an albumin fusion protein having GLP-1 activity, comprising two tandem-directed GLP-1 polypeptides (7-36 (A8G)) fused to human serum albumin; such as an albumin fusion protein having GLP-1 activity, comprising the amino acid sequence 30-674 of SEQ ID NO: 1280 of EP1463751 such as ALBIGLUTIDE;
AU2014206217B2 (en) Extended recombinant polypeptides and compositions comprising same
OSHIKA et al. Human parathyroid hormone: efficient synthesis in Escherichia coli using a synthetic gene, purification and characterization
Kolodny et al. Two-step chromatographic purification of recombinant Plasmodium falciparum circumsporozoite protein from Escherichia coli
WO2005094870A3 (en) Use of osteopontin fragment svvglr-derived peptides for the treatment of ischemic diseases
AU2017200870B2 (en) Extended recombinant polypeptides and compositions comprising same
WO2002012475A3 (en) C1q-related factor, homologous polypeptides and therapeutic uses thereof
WO2003023006A3 (en) Hemocyanin nucleic acids and polypeptides and related vectors, fusion proteins, conjugates, cells and methods of use